Valneva SE updates
Sign up to myFT Daily Digest to be the first to know about Valneva SE news.
The UK has terminated an agreement with France-based biotech company Valneva for the supply of at least 100m doses of Covid-19 vaccine, saying the company was in breach of its obligations under the deal.
The company “strenuously” denied the claim in a statement on Monday. The deal was worth up to €1.4bn, with manufacturing due to take place in Scotland and deliveries due to start in 2022.
The vaccine candidate uses a whole inactivated virus to elicit an immune response against